Skip to main content

IOANNIS GRIVEAS

MD,PhD

Presentations

  • 107. Comparison of efficacy between alteplase and urokinase against thrombosis of catheters in hemodialysis.
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 108. Kinetics of ferritin in hemodialysis patients after iv. administration of Fe.
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 109. Comparison between hemodialysis path with citrate acids and acetic acids.
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 110. Follow up of pauce-immune-necrotizing-rapidly progressive glomerulonephritis
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    10th BANTAO CONGRESS, Chalkidiki, 13-15/2/2011.
  • 111. The contribution of folic acid in diagnosis of functional lack of Fe in hemodialysis patients.
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 112. Acute Renal Failure: Epidemiological data in hospitalized patients
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos, P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 113. Five years experience of therapeutic apheresis of immune diseases in a nephrology department.
    I. Griveas, G. Visvardis, E. Manou, D. Meimaridou, E. Mitsopoulos , P. Kyriklidou, D. Papadopoulou, E. Ginikopoulou, G. Sakellariou.
    Department of Nephrology, Papageorgiou General Hospital.
    14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 114. Initial dosing of paricalcitol based on parathormone levels in haemodialysis patients with mild and moderate secondary hyperparathyroidism: is PTH/80 the most appropriate?
    E. Mitsopoulos1, E. Ginikopoulou1, P. Kyriklidou1, R. Zilidou2, D. Papadopoulou1, A. Fleva1, G. Visvardis1, E. Manou1, D. Meimaridou1, I. Griveas1, A. Pavlitou2, G. Sakellariou1.
    1 Nephrology Dpt, 2 Immunology Dpt, Papageorgiou General Hospital, Thessaloniki, Greece.
    XLIII Congress of ERA EDTA in Glasgow, 15-18 July, 2006 and 14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 115. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocytes with different dialyzers
    I. Griveas, P. Pasadakis, A. Fleva, G. Visvardis, D. Papadopoulou, E. Mitsopoulos, P. Kyriklidou, E. Manou, E. Ginikopoulou, D. Meimaridou, A. Pavlitou, V. Vargemezis, G. Sakellariou.
    Nephrology Department, Papageorgiou General Hospital, Thessaloniki, Greece.
    XLIII Congress of ERA EDTA in Glasgow, 15-18 July, 2006 and 14th Hellenic Congress of Nephrology, Chalkidiki 31/5-3/6/2006.
  • 116. Effects of dialysis membrane nature on intradialytic phagocytizing activity and oxidative burst.
    I. Griveas, P. Passadakis, A. Fleva, E. Thodis, G. Stavianoudakis, A. Pavlitou, V. Vargemezis.
    Nephrology Department, 417 Veterans Army Administration Hospital (NIMTS), Athens, Greece and Medical School –University of Thrace, Alexandropolis, Greece.
    25th Annual Meeting of the International Society of Blood Purification (ISBP), September 15-17, Prague, Czech Republic.
  • 117. Effective treatment of haemodialysis patient with calciphylaxis.
    I. Griveas, K. Mastrodimitri, I. Kiritsis, E. Stamataki, S. Zorbas, S. Ioneskou, C. Andriopoulos, G. Stavianoudakis.
    Nephrology Department, 417 Veterans Army Administration Hospital (NIMTS), Athens, Greece.
    74th Meeting of Hellenic Nephrology Society, 22-23 November 2007, Thessaloniki, Greece.
  • 118. Secondary amyloidosis in patient with rheumatoid arthritis without proteinuria.
    I. Griveas, K. Mastrodimitri, I. Kiritsis, E. Stamataki, S. Zorbas, S. Ioneskou, C. Andriopoulos, G. Stavianoudakis.
    Nephrology Department, 417 Veterans Army Administration Hospital (NIMTS), Athens, Greece.
    74th Meeting of Hellenic Nephrology Society, 22-23 November 2007, Thessaloniki, Greece.
  • 119. Evaluation of cyclosporine as main therapeutic regimen in patients with idiopathic nephrotic syndrome.
    I. Griveas, K. Mastrodimitri, I. Kiritsis, E. Stamataki, S. Zorbas, S. Ioneskou, C. Andriopoulos, G. Stavianoudakis.
    Nephrology Department, 417 Veterans Army Administration Hospital (NIMTS), Athens, Greece.
    74th Meeting of Hellenic Nephrology Society, 22-23 November 2007, Thessaloniki, Greece.
  • 120. Serum Cr sensitivity is inadequate to predict adverse outcomes following very severe peripheral vascular surgery. Is the widespread use of GFR justified for a critical section of the population?
    D. Koumoutsea, V. Tsiligiris, E. Chouliaras, I. Griveas, V. Tzilalis, I.Angelakas, G. Stavianoudakis, K. Karamitsos.
    23rd World Congress of the International Union of Angiology, Athens, 21-25 June 2008.
  • 121. The impact of obesity and the effect of type of assessment on AVF survival in patients on hemodialysis.
    I. Griveas, et al.
    Nephrology Department 417 NIMTS, Athens.
    1st International Diabetes and Obesity Forum, Athens 21-23 October 2010.